RBC Bioscience Corporation (TPEX:6848)
16.25
-0.25 (-1.52%)
Feb 11, 2026, 2:07 PM CST
RBC Bioscience Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 60.98 | 79.86 | 65.18 | 75.93 | 97.47 | 123.94 |
Cash & Short-Term Investments | 60.98 | 79.86 | 65.18 | 75.93 | 97.47 | 123.94 |
Cash Growth | -20.52% | 22.53% | -14.16% | -22.10% | -21.36% | 186.50% |
Accounts Receivable | 28.41 | 13.49 | 23 | 25.59 | 24.68 | 51.85 |
Other Receivables | 0.25 | 1.27 | 0.7 | 0.71 | 1.33 | 7.17 |
Receivables | 28.66 | 14.76 | 23.7 | 26.3 | 26.01 | 59.01 |
Inventory | 50.38 | 52.76 | 44.42 | 47.2 | 51.2 | 60.78 |
Other Current Assets | 9.85 | 9.43 | 6.91 | 7.47 | 33.95 | 63.17 |
Total Current Assets | 149.88 | 156.8 | 140.21 | 156.9 | 208.62 | 306.91 |
Property, Plant & Equipment | 512.39 | 520.97 | 533.54 | 556.74 | 621.22 | 90.94 |
Other Intangible Assets | 11.85 | 12.87 | 3.14 | 2.45 | 3.17 | 3.54 |
Long-Term Deferred Tax Assets | 3.53 | 3.53 | 3.26 | 3.41 | 4.09 | 2.9 |
Other Long-Term Assets | 79.98 | 69.71 | 73.63 | 71.05 | 10.51 | 108.33 |
Total Assets | 757.62 | 763.88 | 753.79 | 790.55 | 847.6 | 512.62 |
Accounts Payable | 23.61 | 23.77 | 15.72 | 22.71 | 35.75 | 101.06 |
Accrued Expenses | - | 13.04 | - | - | - | 55.15 |
Short-Term Debt | 25 | 25 | 35 | 40 | 64.65 | 71 |
Current Portion of Long-Term Debt | 32.57 | 27.92 | 23.03 | 22.69 | 2.11 | 1.92 |
Current Portion of Leases | 0.96 | 1.13 | 1.02 | 1.77 | 1.98 | 5.97 |
Current Income Taxes Payable | 8.11 | 4.92 | 1.26 | 8.51 | 8.05 | 36 |
Current Unearned Revenue | 0.49 | 0.92 | 0.31 | 0.26 | 1.34 | 0.48 |
Other Current Liabilities | 25.88 | 14.91 | 23.43 | 27.8 | 34.2 | 15.47 |
Total Current Liabilities | 116.61 | 111.6 | 99.77 | 123.74 | 148.07 | 287.05 |
Long-Term Debt | 377.65 | 399.8 | 412.33 | 416.63 | 439.82 | 37.98 |
Long-Term Leases | 0.41 | 0.85 | 0.27 | 0.66 | 2.43 | 3.61 |
Long-Term Unearned Revenue | 0.64 | 0.61 | 0.43 | 0.43 | 0.45 | 0.25 |
Pension & Post-Retirement Benefits | - | 1.44 | - | - | - | - |
Other Long-Term Liabilities | 1.84 | 0.29 | 0.29 | 0.29 | - | 9 |
Total Liabilities | 497.15 | 514.58 | 513.08 | 541.73 | 590.77 | 337.89 |
Common Stock | 129.76 | 129.76 | 129.76 | 129.76 | 117.96 | 71.9 |
Additional Paid-In Capital | 50.45 | 50.45 | 50.45 | 50.45 | 50.45 | - |
Retained Earnings | 67.29 | 69.09 | 60.5 | 68.61 | 88.42 | 102.83 |
Comprehensive Income & Other | 12.98 | - | - | - | - | - |
Shareholders' Equity | 260.47 | 249.3 | 240.71 | 248.81 | 256.83 | 174.73 |
Total Liabilities & Equity | 757.62 | 763.88 | 753.79 | 790.55 | 847.6 | 512.62 |
Total Debt | 436.59 | 454.7 | 471.65 | 481.75 | 510.99 | 120.47 |
Net Cash (Debt) | -375.6 | -374.84 | -406.47 | -405.82 | -413.52 | 3.47 |
Net Cash Per Share | -26.13 | -26.09 | -28.42 | -28.35 | -30.57 | 0.26 |
Filing Date Shares Outstanding | 14.27 | 14.27 | 14.27 | 14.27 | 14.27 | 13.06 |
Total Common Shares Outstanding | 14.27 | 14.27 | 14.27 | 14.27 | 14.27 | 12.18 |
Working Capital | 33.27 | 45.2 | 40.45 | 33.16 | 60.55 | 19.86 |
Book Value Per Share | 18.25 | 17.47 | 16.86 | 17.43 | 17.99 | 14.35 |
Tangible Book Value | 248.62 | 236.43 | 237.57 | 246.36 | 253.66 | 171.19 |
Tangible Book Value Per Share | 17.42 | 16.56 | 16.64 | 17.26 | 17.77 | 14.06 |
Land | 354.26 | 354.26 | 354.26 | 354.26 | 401.43 | 47.17 |
Buildings | 166.99 | 170.11 | 170.11 | 183.13 | 193.16 | 10.03 |
Machinery | 77.2 | 76.3 | 75.96 | 69.14 | 60.79 | 60.89 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.